ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Mega-Cap Week: Microsoft, Amazon, Apple Queue Up

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Today Porsche AG kicks off a busy week for auto earnings. The German carmaker reports alongside a slate of Asian banks. Later today, Société Générale will also be watched after a mixed year.

Tomorrow is the week's busiest day. Microsoft ($3.95 trillion market cap) releases after the close. Amazon follows on Wednesday alongside Intel. Chipotle Mexican Grill and Align Technology also post Tuesday. Amphenol holds its earnings call Tuesday morning.

European auto results dominate mid-week. Mercedes-Benz reports Tuesday. Dutch car registrations ran 6% below year-ago levels through all three months of the quarter, per ORTEX alt data, a strong-fit leading indicator for Mercedes revenue. Volkswagen follows Wednesday. Austrian car registrations, a moderate-fit lead for VW revenue, also ran down 6% year-on-year. Renault reports Wednesday too. Its Dutch registration signal, a moderate-fit lead, ran 19% below year-ago levels.

Bristol-Myers Squibb posts Wednesday morning. BorgWarner reports the same day.

Thursday brings Apple ($5 trillion market cap) after the close. Check Point Software and Aehr Test Systems also report that day.

No confirmed IPOs are scheduled in the next seven days on the ORTEX calendar.

The MSCI World November review announcement is due 11 November. Moderna sits 75% above the MSCI World entry line. ORTEX forecasts an 88% probability of addition, with tracker buying estimated at $4.4 billion.

Stocks in this article

How this article was generated

Generated
27 Oct 2026, 20:31
Prompt version
v1.0
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.